This page was printed from the South & West Devon Formulary and Referral site at
Please ensure you are using the current version of this document
See here for end of life symptom control for patients dying of COVID-19 infection
Just in Case Bags (JICB) formalise anticipatory prescribing towards the end of life when a clinical deterioration is anticipated but the patient does not yet need as required subcutaneous injections or a syringe pump for current symptom control.
The availability of anticipatory prescribing can minimise distress to the patient and their family by having such medications readily accessible for when they might be needed.
Once the patient has a syringe pump in situ, there is no longer a need for JICB, as required medication should be prescribed.
The prescriber should ensure that all relevant agencies are informed that the JICB is within the care setting; this can be achieved via the Electronic Patient Care Co-ordination System (EPaCCS).
Please refer to local Just in Case information:
Refer to 16.1 Palliative care services: contact details, resources for further information.
See here for end of life symptom control for patients dying of COVID-19
*Consider whether patient is opiate naïve or if there is a requirement for high dose for breakthrough pain if on regular opiate.
Authorisations form for administration of Just in Case medications must also be completed by the prescriber.
Please refer to the Care of the dying person section